Karen Andersen, CFA, of Morningstar shares the firm’s thinking and broader trends shaping the development of coronavirus treatments in an interview with GEN Edge . . .
Assessing Coronavirus Impact on Wall Street
Exclusive: Morningstar’s Karen Andersen, CFA, Discusses the Outbreak’s Potential Impact on Life Sciences Stocks
Karen Andersen, CFA, Healthcare Strategist with Morningstar, says the coronavirus outbreak has resulted in “a lot more companies entering the space, and a few more companies volunteering more information on some of their development timelines, too.” [Morningstar]
